Adding high-sensitivity cardiac troponin assays on top of conventional risk-prediction methods can potentially improve primary prevention efforts, according to a new meta-analysis. While best known ...
CHICAGO, IL—Just one in three US hospitals are currently using high-sensitivity cardiac troponin (hs-cTn) assays, although that number appears to be on the rise, according to results of a new study.
In a recent study published in the journal BMJ, a team of researchers from the United Kingdom evaluated the use of a high-sensitivity assay to measure cardiac troponin I and its impact on myocardial ...
Switching from a conventional to a high-sensitivity cardiac troponin I assay in emergency departments is associated with a reduction in both mortality at 1 year and new admissions for myocardial ...
Join this webinar to explore the growing health economic evidence supporting the use of high‑sensitivity Troponin I (hs‑TnI) in cardiovascular disease (CVD) risk stratification. Drawing on multiple ...
An artificial intelligence (AI) model trained to detect blocked coronary arteries based on electrocardiogram (ECG) readings performed better than expert clinicians and was on par with troponin T ...
Please provide your email address to receive an email when new articles are posted on . High-sensitivity troponin I levels at 14, 22 and 29 weeks’ gestation were higher among women who went on to ...
Most hospitals in the United States have yet to transition from conventional to high-sensitivity cardiac troponin (hs-cTn) assays, despite their greater sensitivity for myocardial injury, a new ...
A prospective cohort study of 13,862 patients showed that among those who underwent isolated coronary-artery bypass grafting or aortic-valve replacement or repair, the threshold high-sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results